Patent Assignment
Reel/Frame 072131/0540
Assignment of Assignor's Interest
Recorded: 2025-07-22
Pages: 18
Assignor
ENDO OPERATIONS LIMITED
Executed: 2025-07-16
Assignee
PH HEALTH LIMITED
FIRST FLOOR MINERVA HOUSE, SIMMONSCOURT ROAD, BALLSBRIDGE, DUBLIN 4, D04 H9P8, IRELAND
Covered Properties
(49)
Epinephrine Formulations
Patent:
9,119,876 →
Application:
14/657,990 →
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Patent:
9,375,478 →
Application:
14/717,882 →
Epinephrine Formulations
Patent:
9,295,657 →
Application:
14/818,121 →
Epinephrine Formulations
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Epinephrine Formulations
Vasopressin Formulations for Use in Treatment of Hypotension
Vasopressin Formulations for Use in Treatment of Hypotension
Epinephrine Formulations
Pre-Filled Syringe Containing Sugammadex
Patent:
11,097,023 →
Application:
16/919,790 →
Peptide Congeners with Polymer Excipients
Application:
17/104,102 →
Publication:
US 2021/0077568
Phenylephrine Hydrochloride Compositions and Containers
Application:
17/154,516 →
Publication:
US 2021/0228507
N-Acetylcysteine Compositions and Methods
Isoproterenol Compositions and Methods
Vasopressin Formulations for Use in Treatment of Hypotension
Epinephrine Formulations
Epinephrine Formulations
Application:
17/694,165 →
Publication:
US 2023/0285326
Varenicline Compound and Process of Manufacture Thereof
N-Acetylcysteine Compositions and Methods
Varenicline Compound and Process of Manufacture Thereof
Patent:
11,717,524 →
Application:
17/930,824 →
Varenicline Compound and Process of Manufacture Thereof
Application:
17/930,940 →
Publication:
US 2023/0285404
Hydralazine Compositions and Methods
Vareniciline Compound and Process of Manufacture Thereof
Sodium Bicarbonate Injectable Formulation and Methods Thereof
Application:
18/278,153 →
Publication:
US 2024/0131056
Varenicline Compound and Process of Manufacture Thereof
N-Acetylcysteine Compositions and Methods
Isoproterenol Compositions and Methods
Epinephrine Formulations
Injectable Sustained Release Pharmaceutical Composition
Application:
18/712,628 →
Publication:
US 2025/0009646
Phenylephrine Hydrochloride Compositions and Containers
Hydralazine Compositions and Methods
Application:
18/824,377 →
Publication:
US 2025/0177390
N-Acetylcysteine Compositions and Methods
Application:
18/830,389 →
Publication:
US 2024/0423905
Vasopressin Formulations for Use in Treatment Of Hypotension
Application:
18/985,947 →
Publication:
US 2026/0041729
Oxytocin Compositions and Methods
Application:
19/008,443 →
Publication:
US 2025/0213648
Epinephrine Formulations
Application:
19/082,319 →
Publication:
US 2026/0034074
Sodium Bicarbonate Injectable Formulation and Methods Thereof
Application:
19/196,581 →
Publication:
US 2025/0302870
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 26, 2016
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICALS, INC.
Reel/Frame 040491/0176 →
Assignment of Assignor's Interest
Mar 2, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 041442/0453 →
Assignment of Assignor's Interest
Mar 2, 2017
From: KENNEY, MATTHEW; KANNAN, VINAYAGAM; VANDSE, SUNIL; SANGHVI, SUKETU
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 041442/0482 →
Confirmatory Grant of Security Interest in United States Patents
May 26, 2020
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052752/0269 →
Confirmatory Grant of Security Interest in United States Patents
Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0618 →
Confirmatory Grant of Security Interest in United States Patents
Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055846/0246 →
Confirmatory Grant of Security Interest in United States Patents
Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
Assignment of Assignor's Interest
Apr 23, 2024
From: PAR PHARMACEUTICAL, INC.
To: ENDO USA, INC.
Reel/Frame 067203/0686 →
Release of Security Interest
Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0542 →
Release of Security Interest
Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC
Reel/Frame 067239/0491 →
Release of Security Interest
Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067239/0795 →
Release of Security Interest
Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
Release of Security Interest
Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC
Reel/Frame 067239/0682 →
Assignment of Assignor's Interest
Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
Security Interest
Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
Security Interest
Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
Assignment of Assignor's Interest
Jul 21, 2025
From: ENDO OPERATIONS LIMITED
To: PH HEALTH LIMITED
Reel/Frame 071778/0632 →
Release of Security Interest in Certain Patents Previously Recorded at Reel/Frame (068461/0692)
Aug 4, 2025
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: ENDO OPERATIONS LIMITED
Reel/Frame 072343/0897 →
Short Form Intellectual Property Security Agreement
Nov 6, 2025
From: PH HEALTH LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 073508/0830 →